Protagonist Therapeutics, Inc (PTGX) /
The debt of Protagonist Therapeutics, Inc over the past 10 years
Chart Protagonist Therapeutics, Inc: liquid cash, total debt, net cash, fiscal 2016–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, Protagonist Therapeutics, Inc had liquid cash of $567.36M and total debt of $0: net cash of $567.36M. It had more liquid cash than debt at all 10 year-ends shown. Total debt was highest at the end of fiscal 2019 ($9.79M) and lowest at the end of fiscal 2016 ($0).
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $567.36M* | $0 | $567.36M |
| 2024ended Dec 31, 2024 | $418.91M* | $0 | $418.91M |
| 2023ended Dec 31, 2023 | $341.62M* | $0 | $341.62M |
| 2022ended Dec 31, 2022 | $237.35M* | $0 | $237.35M |
| 2021ended Dec 31, 2021 | $326.9M* | $0 | $326.9M |
| 2020ended Dec 31, 2020 | $305.81M* | $0 | $305.81M |
| 2019ended Dec 31, 2019 | $133.01M* | $9.79M | $123.21M |
| 2018ended Dec 31, 2018 | $128.85M* | $0 | $128.85M |
| 2017ended Dec 31, 2017 | $144M* | $0 | $144M |
| 2016ended Dec 31, 2016 | $77.6M* | $0 | $77.6M |
Fiscal years as Protagonist Therapeutics, Inc reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Protagonist Therapeutics, Inc
- The revenue of Protagonist Therapeutics, Inc
- The profitability of Protagonist Therapeutics, Inc
- The cash flow of Protagonist Therapeutics, Inc
- All of Protagonist Therapeutics, Inc's financials, charted
Companies of a similar size
Not investment advice. This page shows what Protagonist Therapeutics, Inc filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.